Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Karrie Wang"'
Autor:
Mythili Koneru, Shukaib Arslan, Margarida Magalhaes Magalhaes-Silverman, Hongtao Liu, Nelli Bejanyan, Antonio Di Stasi, Robin McCallum, Silvia Quintero, Gerald Garrett, Karrie Wang, Eric Smith, Tara Shahim, Lina Hoang, Jeannette Crisostomo, Anna Wilga-Savitski, Jennifer Pickering, Laura Angelo, Anastasiya Smith, Juan F. Vera, Betul Oran, Jingmei Hsu
Publikováno v:
Blood. 140:12718-12719
Autor:
Shukaib Arslan, Jingmei Hsu, Betul Oran, Alejandro Sica, Hongtao Liu, Margarida Silverman, Nelli Bejanyan, Antonio DiStasi, Robin McCallum, Silvia Quintero, Gerald Garrett, Karrie Wang, Eric Smith, Tsvetelina Hoang, Tara Shahim, Jeannette Crisostomo, Anna Wilga-Savitski, Jennifer Pickering, Laura Angelo, Anastasiya Smith, Juan Vera, Mythili Koneru
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S213-S214
Autor:
Shukaib Arslan, Jingmei Hsu, Betul Oran, Alejandro Sica, Hongtao Liu, Margarida Silverman, Nelli Bejanyan, Antonio DiStasi, Robin McCallum, Silvia Quintero, Gerald Garrett, Karrie Wang, Eric Smith, Tsvetelina Hoang, Tara Shahim, Jeannette Crisostomo, Anna Wilga-Savitski, Jennifer Pickering, Laura Angelo, Anastasiya Smith, Juan Vera, Mythili Koneru
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S125
Autor:
Sagar Lonial, Trisha Piontek, Peter M. Voorhees, Al-Ola Abdallah, January Baron, Axel Hoos, Joanna Opalinska, Scott Richmond, Julie Byrne, Ira Gupta, Paul G. Richardson, Prashant Kapoor, Hans C. Lee, Karrie Wang, Roxanne C. Jewell, Adam D. Cohen
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 10, Iss 10, Pp 1-11 (2020)
Blood Cancer Journal, Vol 10, Iss 10, Pp 1-11 (2020)
DREAMM-2 (NCT03525678) is an ongoing global, open-label, phase 2 study of single-agent belantamab mafodotin (belamaf; GSK2857916), a B-cell maturation antigen-targeting antibody-drug conjugate, in a frozen-liquid presentation in patients with relapse
Autor:
Karrie Wang, Mary-Ellen Taplin, Benjamin H Lowentritt, Wassim Abida, Geraldine Ferron-Brady, David R. Wise, Olena Barbash, Begoña Mellado, Vivek Narayan, Doug Fecteau, Joshua Michael Lang, Joan Carles, Arindam Dhar, Johann S. de Bono, Arun Azad, M Isabel Sáez, Ahmed Khaled, Ulka N. Vaishampayan
Publikováno v:
Journal of Clinical Oncology. 36:TPS391-TPS391
TPS391 Background: Metastatic castrate-resistant prostate cancer (mCRPC) remains an incurable illness as resistance develops after androgen deprivation therapy (ADT) and/or androgen receptor (AR) axis targeted therapies. The bromodomain (BRD) and ext